Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.38
Bid: 40.24
Ask: 40.36
Change: 0.22 (0.55%)
Spread: 0.12 (0.298%)
Open: 40.88
High: 40.88
Low: 40.00
Prev. Close: 40.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
28th Mar 20113:44 pmRNSAcquisition Update
16th Mar 20115:24 pmRNSDirector/PDMR Shareholding
7th Mar 20117:06 amRNSHolding(s) in Company
7th Mar 20117:00 amRNSReceipt of Assura monies and Special Interim Divi
24th Feb 20112:55 pmRNSHolding(s) in Company
23rd Feb 20114:14 pmRNSHolding(s) in Company
23rd Feb 20114:08 pmRNSHolding(s) in Company
23rd Feb 20114:04 pmRNSHolding(s) in Company
21st Feb 20112:24 pmRNSAdmission of ordinary shares
18th Feb 20113:31 pmRNSHolding(s) in Company
18th Feb 201111:35 amRNSHolding(s) in Company
18th Feb 201111:11 amRNSDirector/PDMR Shareholding
18th Feb 201110:39 amRNSRule 8 Announcement
18th Feb 201110:10 amRNSRule 8 Announcement
18th Feb 20117:00 amRNSAcquisition: First Closing Date
18th Feb 20117:00 amPRNFirst Closing Date: Offer Unconditional
17th Feb 20115:26 pmRNSRule 8 Announcement
17th Feb 20115:26 pmRNSRule 8 Announcement
17th Feb 20114:22 pmRNSHolding(s) in Company
17th Feb 20112:47 pmBUSForm 8.3 - ASSURA GROUP LTD
17th Feb 20112:21 pmBUSForm 8.3 - Assura Group Limited
17th Feb 201112:53 pmRNSEGM Results
17th Feb 201110:03 amRNSRule 2.10 Announcement
16th Feb 20117:00 amRNSResult of Open Offer
15th Feb 20113:32 pmPRNResult of EGM
10th Feb 20117:00 amRNSInterim Management Statement
27th Jan 20113:00 pmRNSPublication of Prospectus
27th Jan 20113:00 pmPRNPublication of Prospectus, Circular and Offer Document
21st Jan 20113:18 pmRNSHolding(s) in Company
20th Jan 20111:32 pmBUSForm 8.3 - Assura Group Limited
20th Jan 20111:00 pmBUSForm 8.3 - Assura Group Limited
19th Jan 20117:00 amRNSOffer for AH Medical Properties plc
19th Jan 20117:00 amPRNRecommended Offer by Assura Group for AH Medical
10th Jan 20114:40 pmRNSSecond Price Monitoring Extn
10th Jan 20114:35 pmRNSPrice Monitoring Extension
5th Jan 20113:22 pmBUSForm 8.3 - Assura Group Limited
24th Dec 201010:27 amRNSForm 8 (OPD) - Assura Group Limited
23rd Dec 20103:14 pmBUSForm 8.3 - Assura Group Limited
21st Dec 20102:59 pmRNSForm 8 (OPD) Assura Group Ltd
21st Dec 20101:30 pmBUSForm 8.3 - Assura Group Limited
16th Dec 201010:46 amRNSForm 8.3 - Assura Group Limited
14th Dec 20101:22 pmBUSForm 8.3 - Assura Group Limited
13th Dec 20101:44 pmBUSForm 8.3 - Assura Group Ltd
10th Dec 20102:43 pmRNSPotential Acquisition
23rd Nov 20107:00 amRNSHalf Yearly Report
12th Nov 20102:46 pmRNSNotification of Major Interest in Shares
28th Oct 20102:58 pmRNSNotice of Results
12th Oct 20104:40 pmRNSSecond Price Monitoring Extn
12th Oct 20104:35 pmRNSPrice Monitoring Extension
9th Sep 20102:57 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.